|Bid||0.0000 x 43500|
|Ask||0.0000 x 21500|
|Day's range||2.3300 - 3.0000|
|52-week range||1.1600 - 6.2800|
|Beta (5Y monthly)||2.28|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Image source: The Motley Fool. Bionano Genomics, Inc (NASDAQ: BNGO)Q2 2022 Earnings CallAug 04, 2022, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood day, and welcome to the Bionano Genomics second quarter 2022 earnings conference call.
Now's a great time to invest in companies with the potential to grow significantly in the long term.
Bionano Genomics, Inc. (BNGO) delivered earnings and revenue surprises of -10% and 7.58%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?